Opioid use disorder can be a contributing factor to Americans landing in the nation's prisons and jails, but those inmates typically have no access to medications that could help wean them off the drugs.

Despite two-thirds of incarcerated people having substance use disorder, a new study reveals a lack of therapy options.

Just 44 percent of jails offer incarcerated people with opioid use disorder medications like methadone, buprenorphine or naltrexone to treat addiction, according to a new analysis of 1,028 jails from the National Institute of Drug Abuse.

So finds a new study of over 900 jails nationwide. More than half offered inmates no access to medications against opioid use disorder, said a team of researchers from the University of Chicago. “Offering substance use disorder treatment in justice settings helps to break the debilitating -- and often fatal -- cycle of addiction and incarceration,

Medication for opioid use disorder can save lives. But fewer than half of jails surveyed across the country provide it, a new study found.

Minnesota is seeking a Medicaid waiver to help cover incarcerated people’s health care, including substance use treatment, and has a new workgroup focused on the problem.

Few U.S. jails offer medications for opioid use disorder (MOUD), according to a study published online Sept. 24 in JAMA Network Open. Elizabeth Flanagan Balawajder, M.P.H., from NORC at the University of Chicago,